10.1016/0003-2697(79)90738-3 41 OmoruyiF.BudiamanA.EngY.OlumeseF.HoeselJ.EjilemeleA.et al (2013)
Semaglutide, sold under the brand names Ozempic, Wegovy, and Rybelsus, is a prescription medication for type 2 diabetes and long-term weight management
But here's what the article also shows: employers who paired GLP-1s with structured clinical support started seeing overall healthcare costs come down after 1824 months
When you are well enough, you can reach out to our Dallas-Fort Worth GLP-1 lawsuit attorneys for a free case review
For everyone else, it provides context for informed decision-making rather than a reason to avoid potentially life-changing treatment
Realistic launch: 2032 at the earliest, unless patent settlements or court rulings speed things up